FDA Inspection
LE PAPILLON LTD.LE PAPILLON LTD. – FDA Inspection, Jun 5, 2025
Record Details
This FDA Inspection record concerns LE PAPILLON LTD., with an inspection on June 5, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · a927d759-dbab-43be-8a7d-f7cd65c9129b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1271807
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LE PAPILLON LTD.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LE PAPILLON LTD.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.